Sfoglia per Rivista MEDICAL ONCOLOGY
Mostrati risultati da 1 a 2 di 2
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B)
2013-01-01 Formica, V; Cereda, V; di Bari, Mg; Grenga, I; Tesauro, M; Raffaele, P; Ferroni, P; Guadagni, F; Roselli, M
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients
2014-01-01 Formica, V; Luccchetti, J; Cunningham, D; Smyth, Ec; Ferroni, P; Nardecchia, A; Tesauro, M; Cereda, V; Guadagni, F; Roselli, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) | 1-gen-2013 | Formica, V; Cereda, V; di Bari, Mg; Grenga, I; Tesauro, M; Raffaele, P; Ferroni, P; Guadagni, F; Roselli, M | |
| Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients | 1-gen-2014 | Formica, V; Luccchetti, J; Cunningham, D; Smyth, Ec; Ferroni, P; Nardecchia, A; Tesauro, M; Cereda, V; Guadagni, F; Roselli, M |
Mostrati risultati da 1 a 2 di 2
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile